559
2135585226014562116168
ORIGINÁLNÍ3862207016996181224324367468561635735777
PRÁCE4677207016983165262348424
Ces37047936014570127174
Urol39037936014578115180208
2020;41367936014562121178237261
24(3):44237936014561118151209238260
207–21347097936014561121178231286341393
5.62489601335778
Poršová726896013367125162206267319373
M,1130896013389114
Kolombo1267896013368128154215308370432
I,172389601333457
Porš1804896013367126162206
J,203489601334970
Pabišta2128896013367119182208251288342
R.249489601336793
Možnosti2619898013186145189248307347382405
prevence3048898013170102154204256315364415
recidivujících348889801314193143165225247297356378400449471520578
infekcí409189801313189117170216264286
močových4410898013191150199256305357405464
cest.4898898013158109150185205
Urolog.6241048013169100156179237298316
praxi964104801316193143191213
2006;12011048013154105160215232
5:1457104801315469
204–209.15501048013154105160217265316370385
6.624119601335679
Ciani727119601336388141201226
O,976119601337696
Arendsen10951196013368103157218280323378438
E,1557119601335477
Romancik16571196013359119211263324373398448
M,21291196013388112
et2265119601335591
al.2380119601335378100
Intravesical2504119801312381113145195242294334356404454476
administration30041198013150109198220278299338373405455487509566625
of3653119801315987
combined37641198013149105195255277335388448
hyaluronic42361198013159105155177234266322381402451
acid4711119801315098120179
(HA)4914119801313097160188
and6241348013150108168
chondroitin8161348013158116174233293325382404438460518
sulfate13581348013149106129157208240292
(CS)1674134801313797149177
for1875134801313795127
the20271348013142100154
treatment2205134801314274126174207297350408440
of2670134801316795
female2790134801313789179228250303
recurrent3118134801314092142200231264316374406
urinary3548134801316799121179228260312
tract3884134801314375125174210
infections:4119134801313189116169219255278336394434452
a45951348013158
European46781348013159115146203264318367425
multicentre6241498013190147169203225273324382413445497
nested11441498013159112152187238298
case1465149801314999138192
–16801498013155
control17581498013149105163195227283306
study.2089149801314074132191240253
BMJ23651498013155140179
Open25671498013174134188246
2016;28361498013154106153200217
6:3076149801315472
e009669.31711498013153107162216270324375390
doi:35841498013160118140157
10.1136/bmjopen-2015-009669.376414980131541011191652062503023404014915135706316857437768228749229669991056111111641218127213241339
7.624164601335667
Parsons7101646013359110144188248308350
CL,10791646013364114137
Greenspans12351646013371106160215276318379431491533
C,1787164601336488
Mulholland18941646013388147172232291317342394453515
S.2428164601335476
The25241648013151110163
primary2707164801316092114202250281332
antibacterial30591648013150107139160219269317353403434456504526
defense36051648013159112139191248287340
mechanism39651648013189142191248296354375414501
of4486164801315887
the4596164801313088140
bladder.4756164801316183131190249302333346
Invest624179801312381128180220255
Urol903179801316999156179
1975;1106179801315499148198212
13:1343179801315398114
72–76.14811798013153105157204252271
8.624194601335680
Morales7271946013388149185237263318361
A,1111194601336792
Emerson12261946013354144199235279339400
L,1649194601335275
Nickel1747194601337398147197251277
JC,20471946013340104128
Lundie21981946013352111172234259313
M.25341946013389113
Intravesical2670194801312381112144194242293334355403453475
hyaluronic31691948013159105155177234265322380402450
acid3643194801315098120179
in3846194801312380
the3951194801313391144
treatment4119194801313466117165197287340398430
of4572194801315987
refractory4683194801313284112145195243280336368419
interstitial624209801312381112163195236270292326348396418
cystitis.10662098013149100141175197231253292311
J14012098013138
Urol14632098013169100157180
1996;1667209801315398152206223
156(1):1914209801315499151179226246263
45–48.22012098013154103158215269289
9.624224601335675
Rooney7272246013359120180241296347
P,1102224601335868
Srivastava1193224601335994119172225267304358408461
A,1682224601336792
Watson18022246013393143178223283344
L,2169224601335680
Quinlan22772246013376136161222247299360
LR,26602246013356115140
Pandit28272246013359110171233258294
A.3148224601336893
Hyaluronic32692248013169117167189246278334393414463
acid37562248013154103125184
decreases39692248013160112162193245293333386426
IL-6441922480131287697154
and45972248013155112172
IL-8479322480131287697152
se‑4969224801314598133
cretion624239801314980132165187245303
and9512398013155112172
permeability11512398013161115146236290338397420442463497548
in1723239801312785
an18322398013154112
inflammatory1968239801312785110137185274363412444500532584
model25802398013191149209262285
of2893239801315987
interstitial3004239801312785117168199240275297330352400423
cystitis.34512398013153104144179201234256295315
Acta37942398013165112148198
Biomater4016239801316082140229278310361393
2015;44332398013158109157202216
19:46742398013158103121
66–75.48192398013158112170218267284
doi:6242548013160118140157
10.1016/j.actbio.2015.8052548013154101119165212260306344368386438486522582605662680735786834879896
02.17252548013153103121
030.18702548013154104156174
10.6242696013356105126
Tay767269601335498146
H,930269601337193
Parsons10402696013358108142185243302343
CL,14002696013364113135
Stein1552269601335487139163221
PC.17902696013359120144
Electrophysiologic1951269801315171123171205235290349406451490510566587644703723770
monitoring27382698013190147204224256310341362418476
of3231269801315986
the3339269801312986137
effects3494269801315380110160208243283
of3795269801315885
soluble3898269801314197119174232254305
virulence4221269801315071101157178229286333382
factors4626269801312372119154209239279
pro‑4922269801316191146180
duced6242848013159115162211269
by9112848013160105
Escherichia1034284801315190137193245274296342398418465
coli15162848013149103125145
infection1683284801311874100150198232253309366
in2071284801311874
urine.2162284801315888109165216232
Urology2412284801316897152173230288335
1996;2764284801315497149201217
48(3):29982848013153106133182205220
389–392.32362848013153103154209256304353369
doi:36232848013159115136152
10.1016/s0090-4295(96)00209-9.379228480131539911515920525129633236641747052257560966371076081083488193395810101063111111611212124612971311
11.6242996013356101118
Cicione773299601336489137162222283338
A,1142299601336792
Cantiello12642996013364117177212237292318343403
F,1691299601336072
Ucciero17942996013371120167192247283342
G,2167299601337195
et2285299601336399
al.2407299601336186108
Intravesical2539299801313189120152202250301342363411461483
treatment3046299801314274125173205295348406438
with35152998013180102135194
highly‑concentrated3733299801316688147205227275307358414473522572630662694744776827887
hyaluronic46442998013167113163185242273330388410458
acid624314801315098120179
and8233148013150107166
chondroitin10093148013149107165223282313370392425447504
sulphate1533314801314197119178237285317368
in1925314801311976
patients20213148013161111143165217274306348
with23893148013179101134192
recurrent2605314801312980129186217250301358390
urinary3015314801315990112169218249300
tract3339314801313162112160196
infections:3559314801311977104156205241263321379418435
results4018314801312980120176198231273
from4315314801312558114203
a45383148013150
multicentre46083148013190147169202224272322380412443495
survey.624329801314197129182234281295
Can9433298013162112170
Urol11373298013169100156179
Assoc13403298013165107146205254
J16183298013138
2014;16803298013154106153200216
8(9–10):1920329801315482131188234282309325
E721–E727.22693298013152104156203252304356408458465
doi:27583298013160118140157
10.5489/cuaj.1989.29393298013154101119173226281333367410468516539557603648701753768
12.6243446013356104127
Goddard7773446013371132195257309344406
JC,12063446013343107131
Janssen1361344601334395156198241296356
DAW.17433446013373137226244
Intravesical2011344801312684115147197245297337358406456478
hyaluronic25163448013159105155177234265322380402450
acid29903448013153102123183
and31973448013152110169
chondroitin33913448013151109167226285316373395429451508
sulfate39233448013144100123151201234285
for4232344801313188120
recurrent4376344801313587136194225257309367399
urinary4801344801315990113170219250302
tract624359801313466116164200
infections:849359801312482109161211247269327385425442
systematic1316359801314291132166217306355388410458
review1798359801313485134157210288
and21103598013152109169
meta‑analysis.23043598013191144177226260309366415437485526547586606
Int2934359801312582114
Urogynecol3074359801316999156216265324377426482505
J36033598013140
2018;36693598013153105153199216
29(7):39113598013153105133186215231
933–942.41683598013154103153208260315364382
doi:45753598013160118140157
10.1007/47583598013154101119165212267316345
s00192-017-3508-z.624374801314194149197242292322378426470497545595647700734774794
13.6243896013356105126
Simmering770389601335478169260315350376436497
JE,1287389601334094117
Tang1424389601335499159220
F,1664389601335466
Cavanaugh17493896013364117167220280332392453513
JE,2282389601334194117
Polgreen24193896013358116142203238293348409
LA,28473896013352121146
Polgreen30133896013358116142203238292348408
PM.34413896013359144168
The36293898013151111164
Increase3817389801311977125157208256295348
in4189389801312077
Hospitalizations42863898013170128168227249282332354375419470502524581639679
for4989389801312582114
Urinary6244048013169100122180228260312
Tract956404801315176126174210
Infections1190404801312078105158207243265323381421
and16314048013150108167
the1822404801313189142
Associated19844048013165107146204254276324356407467
Costs24724048013162118158193235
in2731404801311977
the2832404801313088141
United29944048013168126147181232292
States,3306404801315182132164215255274
1998–2011.3600404801315499153206262309361408449461
Open40824048013174134188246
Forum43494048013150107139197286
Infect,4659404801312078105157207243262
DiS.4941404801317194143162
2017;6244198013154105153197210
4(1):858419801315382130150167
ofw281.1049419801315887169217268315328
Published14014198013155112171194216255312365425
201718514198013153105152196
Feb20714198013151103162
24.22574198013154102120
doi:24014198013159118140157
10.1093/ofid/ofw281.25824198013154101119165212265314351403429456515554607635718765816864876
14.6244346013356106128
Albert773434601336792154210245285
X,1078434601336387
Huertas11864346013372132187223262315358
I,1567434601332447
Pereiró16344346013359112147202227262322
II,197943460133245073
et2073434601335591
al.2185434601335378101
Antibiotics23074348013164122154176236258316348370419460
for2791434801312784116
preventing2928434801316193144193245303335357414474
recurrent3426434801313081131188219252303361393
urinary3840434801315990113170219250302
tract4166434801313163113162198
infection4388434801312078106158207243266323382
in4794434801312078
non­48934348013159117176210
‑pregnant624449801313293124175234291339396427
women.10714498013179135224276333352
Cochrane14424498013162118166223254303360412
Database18744498013170118150199258307346398
Syst2292449801315094134168
Rev24804498013155107155
2004;26554498013153104158212228
2004(3):29034498013153104158213241291315331
CD001209.32544498013162131184239286329380433447
doi:37214498013159117138155
10.1002/14651858.CD001209.389644980131539911716220826231135140044650055059664169274376282189094499810451089113911921207
pub2.6244648013161119178228246
15.6244796013356105126
Rejchrt7724796013359114140188249284323
M,11164796013389113
Havlová12504796013372125176202262313366
K,1638479601335985
Kříž1744479601336097122169
J.1937479601333960
Prevence2019479801315586137186238296344395
recidivujících2438479801313182132154213235284342364386434456504561
uroinfekcí3022479801315889146168226253306351398420
intravezikální3466479801312179111142192240292336359404455477535556
instilací4046479801312179118153175197245294316
kyseliny4384479801314798139192214236294340
hyaluro‑47464798013159105155177234265322357
nové6244948013159117165217
a8654948013150
chondroitinsulfátu9394948013149107165224283315371393427449506546602624653703735793
u17564948013159
pacientů18394948013160110159181233291323380
po22444948013160119
míšním23884948013190111153211233322
poranění.27344948013160120152201259312370391410
Urol.31684948013169100156179198
praxi3390494801316092142190212
2015;36274948013153105153197212
16:38634948013154100118
43.40054948013154103121
16.6245096013356107130
Erikse777509601335489114165211266
BA.10675096013359125150
Randomized,12405098013156105163222280370392436487547565
open,18305098013158118172230248
parallel‑group21025098013161111142192214236289312344406438494552612
study2738509801314175133192241
on30035098013158117
the3144509801313492145
preventive3313509801316193144193245303335357406458
effect3795509801315382112164213250
of4069509801315887
an41805098013150107
estradiol‑releasing4312509801315393128159209269291348372404437488511564612652673731790
vaginal624524801314998156178234282304
ring951524801312850107165
(Estring)1139524801312574115148179201258316343
on15015248013158115
recurrent1640524801312878127183214246296353384
urinary2043524801315889111167215246296
tract2363524801312961109157193
infections2579524801311975102153202237259316373412
in3014524801311975
postmenopausal31095248013160118157191279331388445504553609648697719
women.38475248013179135223275332351
Am42185248013163151
J43935248013133
Obstet44465248013173132171205255288
Gynecol47535248013168113171224272327350
1999;624539801315499152206224
180(5):8725398013154100154183233260277
1072–1079.11735398013154101150202254300347396446462
doi:16595398013160118140157
10.1016/s0002-9378(99)70597-1.1840539801315410111916521226030634438043348854359262267572577382385190095498010271077112811771227125312991312
17.6245546013356104115
Raz7635546013359112160
R,947554601335984
Stamm1055554601335488141232323
WE.14035546013393147170
A15985548013164
controlled16865548013150106165197228285308330382443
trial215355480131356689137159
of2337554801315987
intravaginal2448554801312482113145195243292352374431480502
estriol2975554801315394128160183240263
in3263554801312381
postmenopausal33695548013160120160194284337395453513563620659710732
women41265548013179136226279337
with44885548013179102135193
recurrent4706554801313384134191222255306364396
urinary624569801315890112170219250302
tract950569801313466115164200
infections.1174569801312381109161210246268326385424444
N16425698013170
Engl17365698013151109168190
J19505698013138
Med20125698013186139199
1993;2235569801315499153202218
329(11):24775698013154103154182230271291308
753–756.28095698013153103152208255304356375
doi:32085698013160118141158
10.1056/NEJM199309093291102.33905698013153100118164211263315352423473513597644689743792844898952100510551104115512041244129113411359
18.6245846013356106128
Damiano7785846013373124214238289349408
R,1212584601335983
Quarto13215846013376136187221259317
G,1664584601337294
Bava17855846013359111161213
I,2020584601333052
et2099584601335590
al.221558460133537899
Prevention2341584801315585135183233290321342398456
of2824584801315986
recurrent2933584801313787136192222253304360391
urinary3351584801315989110167215245295
tract3669584801313969118166201
infections3893584801312784110161210245266322380418
by43385848013161107
intravesical4468584801312784114145194240291330350398446467
ad‑49585848013154113145
ministration6245998013190111167188226259290339370391447505
of1152599801315886
hyaluronic12615998013159104153174230260315373393440
acid1725599801315097118176
and19245998013150107165
chondroitin21125998013149106163220279309364385418439495
sulphate:2630599801314197118176233281312362379
a30325998013150
placebo‑controlled3105599801316183130178227286344378428483540571601657679699751810
randomised3938599801313382138197254342363401453512
trial447359980131346586134155
[published4651599801312989146204226246284341393452
correction6246148013148102132163212259294314369426
appears10676148013149106164216262292331
in1420614801311773
Eur15106148013151104133
Urol.1660614801316897151173189
201118666148013153103148187
Jul;2070614801313893113128
60(1):22156148013153105132177196211
193].2443614801315396143166181
Eur26416148013151104133
Urol2792614801316896151172
2011;29816148013153103148187196
59(4):3194614801315399126173197212
645–651.34236148013153106154207261310355365
doi:38056148013160115136151
10.1016/j.eururo.2010.12.039.39736148013153981141582032492933293513684184735035595886426587117608068518679119539691021106811161130
19.6246296013356106125
Arya7776296013368103158211
LA,10116296013357126151
Northington11916296013372133169208268293353414451510570
GM,17906296013371159183
Asfaw20026296013367112144198277
T,2302629601336076
Harvie24076296013371124160216241296
H,2732629601337194
Malykhina28556296013388141167219270333357418470
A.3354629601336792
Evidence34706298013157105128187240297346397
of3891629801316492
bladder4013629801316184132192251304336
oversensitivity43736298013164112164195236289347386408441463512535569620
in5017629801312886
the624644801313492145
absence7916448013150110150203261309360
of1173644801315987
an12826448013150108
infection1414644801312178106158208244266324382
in1820644801312179
premenopausal1921644801316092144233286344402463513570609659681
women26246448013180137227280338
with29846448013179102135193
a31996448013150
history3271644801315981120154210242294
of3587644801315987
recurrent3698644801313082131189220252304362394
urinary4114644801315889112169218249301
tract4439644801313264114163199
infections.4662644801312178106158208244266324382421441
BJU624659801315692160
Int.808659801312381113132
2012;9646598013154105153197215
110(2):1203659801315494141170222248264
247–251.14926598013153101149198245298345357
doi:18736598013160118140157
10.1111/j.1464-410X.2011.10766.x.205465980131541011191652062462873193433614074545095645996557007478048248799309781019103110771124117312211275129413431363
20.6246746013356111133
Gülpınar7826746013371132157219245305357392
O,1200674601337595
Kayış13206746013360114164189232
A,1577674601336892
Süer16956746013354113168204
E,1924674601335477
et2026674601335592
al.2143674601335378101
Clinical2270674801316385106164185234283306
comparision26006748013151107196256306337360399420478536
of3162674801315987
intravesical3273674801312583115147197244296336357406455478
hyaluronic37776748013159105155177234265322380402450
acid42516748013152101123182
and44576748013152110169
hyaluronic46526748013159105155178234266322381402451
acid‑chondroitin624689801315099120179213264321380438498529585608641663721
sulphate1369689801314298121180238287319370
therapy1763689801313594147178228287335
for2122689801313087119
patients22666898013161111143165217275307349
with26406898013179102135193
bladder2859689801316083132192251304335
pain32196898013161111133190
syndrome/interstitital3434689801314291150209241297387440479503560592643674715750772805827861910933
cystitis.43916898013150101141176198231253292312
Can47286898013163113170
Urol4924689801316899156179
Assoc6247048013164106146204254
J9027048013138
2014;9647048013154105153199216
8(9–10):1204704801315482131188234281308325
E610–E614.15537048013151104149196254306359404450468
doi:20457048013160118140157
10.5489/cuaj.2036.22267048013154101119172226281332367410467516538557612663713765784
21.6247196013356107124
De7787196013374129
Vita938719601336188124177
D,1145719601337393
Giordano1268719601337197157193254307367427
S.1718719601336284
Effectiveness1826719801315986116168218254276325377435488528568
of2418719801316694
intravesical2536719801313188120152202249301341363411461483
hyaluronic30437198013166112162184241273329388409458
acid/chondroitin35257198013157106127186226269326385443503534590613646668726
sulfate42757198013148104127155205238289
in4588719801313087
recurrent4699719801314092141199230262314372403
bacterial6247348013160108155190240270292338360
cystitis:1003734801314897136170191223244282299
a13207348013149
randomized1392734801312877133191247335355398448507
study.1917734801314174130188235248
Int2188734801311875105
Urogynecol2312734801316897152211258316367415470492
J28277348013133
2012;28797348013152102149192208
23(12):31067348013153104130176219244260
1707–1713.3384734801315396144192239284326373417434
doi:38367348013159116137153
10.1007/s00192-012-1794-z.40087348013153991151602062593073353704214745215646136426977437868158609029511004103710761095